Programmable DNA-augmented hydrogels for controlled activation of human lymphocytes
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 37, 102442
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration (HL006209)
- National Institute of General Medical Sciences (R01GM120487, R35GM139587)
- Penn State College of Medicine
- National Institutes of Health
This publication has 104 references indexed in Scilit:
- Mechanical Modulation of Receptor-Ligand Interactions at Cell-Cell InterfacesBiophysical Journal, 2012
- Mechanosensing in T Lymphocyte ActivationBiophysical Journal, 2012
- Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicineNature Protocols, 2011
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Structural Organization of the Actin Cytoskeleton at Sites of Clathrin-Mediated EndocytosisCurrent Biology, 2011
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In VivoMolecular Therapy, 2009
- T cell antigen receptor signaling and immunological synapse stability require myosin IIANature Immunology, 2009
- Micropatterning of costimulatory ligands enhances CD4+T cell functionProceedings of the National Academy of Sciences, 2008
- T Cell Receptor-Proximal Signals Are Sustained in Peripheral Microclusters and Terminated in the Central Supramolecular Activation ClusterImmunity, 2006
- A Pathway for Association of Receptors, Adaptors, and Actin during Endocytic InternalizationCell, 2003